Utilize the web fullyThanks to cookies, browsing the web will be easier and more comfortable. To process some of them, we need your consent which you can give by clicking the “Accept all” button. More information about cookies and their settings. By refusing, only essential cookies will be loaded.
Accept all Refuse
Show cookie utilization selection

UO > About > Organizational Structure > Faculties & Institutes > Faculty of Medicine > Departments & Centres > Institute of Laboratory Medicine

Pavel Hradílek


Academic degree, name, surname:
doc. MUDr. Pavel Hradílek, Ph.D.
Room, floor, building:
Position:
Research interests and teaching:
Department (Faculty):
Department of Clinical Neurosciences (Faculty of Medicine)
Department of Biomedical Sciences (Faculty of Medicine)
Phone number, mobile:
+420 597 374 382
E-mail:



No record found.



Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis
Martin Lachnit, Kamila Žondra Revendová, Pavel Hradílek, Radovan Bunganič, Zdeněk Kořístek, Tomáš Jelínek, Monika Skutova, Radim Piza, Ondřej Volný, Roman Hájek, Michal Bar ... other authors
Year: 2024, BIOMEDICAL PAPERS-OLOMOUC
journal article
 
Serum teriflunomide concentrations in routine multiple sclerosis therapy: A cross-sectional pilot study
Zuzana Kušníriková, Ivana Kacířová, Veronika PEŠÁKOVÁ, Pavel Hradílek, Hana Brozmanová, Milan Grundmann ... other authors
Year: 2024, Journal of the Neurological Sciences
journal article
 
Analysis of cerebrospinal fluid cells by flow cytometry: Comparison to conventional cytology
David Zeman, Kamila Revendová, Radovan Bunganic, Marketa Ryzi, Petra Masarovicova, Pavlína Kušnierová, Věra Kotrlová, Pavel Hradílek, David Stejskal, Vojtěch Thon ... other authors
Year: 2023, Biomedical Papers-Olomouc
journal article
 
Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
Pavel Hradílek, Kamila Žondra Revendová, Jana Horakova, Radovan Bunganič, Ondrej Pelisek, David Zeman, Pavla Hanzlíková, Pavlína Kušnierová ... other authors
Year: 2023, BIOMEDICAL PAPERS-OLOMOUC
journal article
 
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries
Tereza Hrnciarova, Jiri Drahota, Tim Spelman, Jan Hillert, Jan Lycke, Eva Kubala Havrdova, Eva Recmanova, Jana Adamkova, Jan Mares, Jana Libertinova, Zbysek Pavelek, Pavel Hradílek, Radek Ampapa, Ivana Stetkarova, Marek Peterka, Alena Martinkova, Pavel Stourac, Marketa Grunermelova, Marta Vachova, Michal Dufek, Dana Horakova ... other authors
Year: 2023, MULTIPLE SCLEROSIS AND RELATED DISORDERS
journal article
 
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
Pavel Hradílek, Olga Zapletalová, Petra Hanulikova, Eva Kubala Havrdova, Ivana Woznicova, Aneta Mazouchova, Jiri Drahota, Michal Lauer, Ivana Stetkarova, Martin Valis, Jana Libertinova, Pavel Stourac, Jana Adamkova, Radek Ampapa, Marta Vachova, Michal Dufek, Alena Martinkova, Marek Peterka, Eva Recmanova, Jan Mares, Dana Horakova ... other authors
Year: 2023, MULTIPLE SCLEROSIS AND RELATED DISORDERS
journal article
 
Liquid chromatography - tandem mass spectrometry method for determination of natalizumab in serum and cerebrospinal fluid of patients with multiple sclerosis
Patrik Matlak, Hana Brozmanová, Pavel Šištík, Ivana Kacířová, Pavel Hradílek, Milan Grundmann ... other authors
Year: 2023, Journal of Pharmaceutical and Biomedical Analysis
journal article
 
Monitorování sérových koncentrací monomethyl fumarátu u pacientů s roztroušenou sklerózou
Ivana Kacířová, Milan Grundmann, Veronika Pešáková, Zuzana Kušníriková Krška, Pavel Hradílek, Hana Brozmanová ... other authors
Year: 2023
abstract in proceedings
 
Terapeutické monitorování natalizumabu u pacientů s roztroušenou sklerózou
Denisa Moškořová, Blanka Kořístková, Pavel Hradílek, Patrik Matlak, Hana Brozmanová, Ivana Kacířová, Milan Grundmann ... other authors
Year: 2023
abstract in proceedings
 
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic
Pavel Hradílek, Eva Meluzinova, Olga Zapletalová, Petra Hanulikova, Dana Horakova, Ivana Woznicova, Lubomir Pavliska, Ivana Stetkarova, Martin Valis, Pavel Stourac, Jana Adamkova, Radek Ampapa, Marta Vachova, Jan Mares ... other authors
Year: 2022, Multiple Sclerosis and Related Disorders
journal article
 
Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center
Radovan Bunganič, S. Blahutova, Kamila Revendová, Olga Zapletalová, Pavel Hradílek, R. Hrdlickova, A. Ganesh, Z. Cermakova, Michal Bar, Ondřej Volný ... other authors
Year: 2022, Scientific Reports
journal article
 
Porovnání hladin biomarkerů axonálního a astrocytického poškození s rutinně používanými biomarkery roztroušené sklerózy
Pavlína Kušnierová, Kamila Revendová, Pavel Hradílek
Year: 2021
abstract in proceedings
 
První zkušenosti s vyšetřením likvorových buněk metodou průtokové cytometrie na ÚLD FN Ostrava
David Zeman, Kamila Revendová, Radovan Bunganič, Markéta Ryzí, Petra Masarovičová, Pavlína Kušnierová, Věra Kotrlová, Pavel Hradílek, David Stejskal, Vojtěch Thon ... other authors
Year: 2021
abstract in proceedings
 

No record found.

View more records

View more records

View more records

View more records

View more records

View more records

View more records

View more records



Author
Title
Type of thesis
Year
Hrubá Kateřina
Relationship between multiple sclerosis and Epstein-Barr virus infection
Master's thesis
2024
Hromádka Filip
The effect of Lokomat therapy on postural stability in patients with multiple sclerosis
Master's thesis
2023
Chudý Miloš
The role of serum vitamin D levels on multiple sclerosis progression
Master's thesis
2022



No record found.

RSS
social hub